Cargando…

Reductions in transdiagnostic factors as the potential mechanisms of change in treatment outcomes in the Unified Protocol: a randomized clinical trial

Transdiagnostic approaches emphasize on the share underlying features of emotional disorders. In their view, these transdiagnostic factors play an important role in the etiology, maintenance, and treatment of emotional disorders. This study aimed to investigate the transdiagnostic factors as the pot...

Descripción completa

Detalles Bibliográficos
Autores principales: Khakpoor, Sahel, Mohammadi Bytamar, Jahangir, Saed, Omid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451383/
https://www.ncbi.nlm.nih.gov/pubmed/32913807
http://dx.doi.org/10.4081/ripppo.2019.379
_version_ 1783574970514800640
author Khakpoor, Sahel
Mohammadi Bytamar, Jahangir
Saed, Omid
author_facet Khakpoor, Sahel
Mohammadi Bytamar, Jahangir
Saed, Omid
author_sort Khakpoor, Sahel
collection PubMed
description Transdiagnostic approaches emphasize on the share underlying features of emotional disorders. In their view, these transdiagnostic factors play an important role in the etiology, maintenance, and treatment of emotional disorders. This study aimed to investigate the transdiagnostic factors as the potential mechanisms of change in the Unified Protocol (UP) for the transdiagnostic treatment of emotional disorders outcomes. The present study is a randomized clinical trial. Twenty-six individuals were selected based on the Beck anxiety inventory and Beck depression inventory and randomly assigned into two groups of control and treatment (n=13). The treatment group received 20 one-hour individual UP sessions. Beck Depression Inventory, Beck Anxiety Inventory, Difficulty in emotion regulation scale, Intolerance of Uncertainty scale and Acceptance and Action questionnaire were carried out in all three phases. UP enhances the difficulty in emotion regulation (large effect size, SEsg=1.81), intolerance of uncertainty (SEsg=1.91), and experiential avoidance (SEsg=1.78). In addition, the results of linear regression show the association between changes in anxiety and depression with changes in transdiagnostic factors. The difficulty in emotion regulation, intolerance of uncertainty and experiential avoidance can be considered as the potential mechanism of change in improving UP outcomes.
format Online
Article
Text
id pubmed-7451383
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-74513832020-09-09 Reductions in transdiagnostic factors as the potential mechanisms of change in treatment outcomes in the Unified Protocol: a randomized clinical trial Khakpoor, Sahel Mohammadi Bytamar, Jahangir Saed, Omid Res Psychother Article Transdiagnostic approaches emphasize on the share underlying features of emotional disorders. In their view, these transdiagnostic factors play an important role in the etiology, maintenance, and treatment of emotional disorders. This study aimed to investigate the transdiagnostic factors as the potential mechanisms of change in the Unified Protocol (UP) for the transdiagnostic treatment of emotional disorders outcomes. The present study is a randomized clinical trial. Twenty-six individuals were selected based on the Beck anxiety inventory and Beck depression inventory and randomly assigned into two groups of control and treatment (n=13). The treatment group received 20 one-hour individual UP sessions. Beck Depression Inventory, Beck Anxiety Inventory, Difficulty in emotion regulation scale, Intolerance of Uncertainty scale and Acceptance and Action questionnaire were carried out in all three phases. UP enhances the difficulty in emotion regulation (large effect size, SEsg=1.81), intolerance of uncertainty (SEsg=1.91), and experiential avoidance (SEsg=1.78). In addition, the results of linear regression show the association between changes in anxiety and depression with changes in transdiagnostic factors. The difficulty in emotion regulation, intolerance of uncertainty and experiential avoidance can be considered as the potential mechanism of change in improving UP outcomes. PAGEPress Publications, Pavia, Italy 2019-12-19 /pmc/articles/PMC7451383/ /pubmed/32913807 http://dx.doi.org/10.4081/ripppo.2019.379 Text en ©Copyright: the Author(s) http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
Khakpoor, Sahel
Mohammadi Bytamar, Jahangir
Saed, Omid
Reductions in transdiagnostic factors as the potential mechanisms of change in treatment outcomes in the Unified Protocol: a randomized clinical trial
title Reductions in transdiagnostic factors as the potential mechanisms of change in treatment outcomes in the Unified Protocol: a randomized clinical trial
title_full Reductions in transdiagnostic factors as the potential mechanisms of change in treatment outcomes in the Unified Protocol: a randomized clinical trial
title_fullStr Reductions in transdiagnostic factors as the potential mechanisms of change in treatment outcomes in the Unified Protocol: a randomized clinical trial
title_full_unstemmed Reductions in transdiagnostic factors as the potential mechanisms of change in treatment outcomes in the Unified Protocol: a randomized clinical trial
title_short Reductions in transdiagnostic factors as the potential mechanisms of change in treatment outcomes in the Unified Protocol: a randomized clinical trial
title_sort reductions in transdiagnostic factors as the potential mechanisms of change in treatment outcomes in the unified protocol: a randomized clinical trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451383/
https://www.ncbi.nlm.nih.gov/pubmed/32913807
http://dx.doi.org/10.4081/ripppo.2019.379
work_keys_str_mv AT khakpoorsahel reductionsintransdiagnosticfactorsasthepotentialmechanismsofchangeintreatmentoutcomesintheunifiedprotocolarandomizedclinicaltrial
AT mohammadibytamarjahangir reductionsintransdiagnosticfactorsasthepotentialmechanismsofchangeintreatmentoutcomesintheunifiedprotocolarandomizedclinicaltrial
AT saedomid reductionsintransdiagnosticfactorsasthepotentialmechanismsofchangeintreatmentoutcomesintheunifiedprotocolarandomizedclinicaltrial